0001209191-18-027652.txt : 20180503
0001209191-18-027652.hdr.sgml : 20180503
20180503163426
ACCESSION NUMBER: 0001209191-18-027652
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180501
FILED AS OF DATE: 20180503
DATE AS OF CHANGE: 20180503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ambrogi Michael J.
CENTRAL INDEX KEY: 0001654363
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 18804361
MAIL ADDRESS:
STREET 1: 195 COMMERCE WAY
CITY: PORTSMOUTH
STATE: NH
ZIP: 03801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Novocure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-01
0
0001645113
Novocure Ltd
NVCR
0001654363
Ambrogi Michael J.
C/O NOVOCURE INC.
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Operating Officer
Ordinary Shares
2018-05-01
4
M
0
28695
3.44
A
175253
D
Ordinary Shares
2018-05-01
4
M
0
31305
7.03
D
206558
D
Ordinary Shares
2018-05-01
4
S
0
60000
27.40
D
146558
D
Options to Buy Ordinary Shares
3.44
2018-05-01
4
M
0
8695
0.00
D
2021-12-13
Ordinary Shares
8695
20000
D
Options to Buy Ordinary Shares
3.44
2018-05-01
4
M
0
20000
0.00
D
2021-12-13
Ordinary Shares
20000
0
D
Options to Buy Ordinary Shares
7.03
2018-05-01
4
M
0
20000
0.00
D
2023-02-19
Ordinary Shares
20000
15195
D
Options to Buy Ordinary Shares
7.03
2018-05-01
4
M
0
11305
0.00
D
2023-02-19
Ordinary Shares
11305
3890
D
These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.
On May 1, 2017, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 60,000 shares in multiple trades at prices ranging from $26.925 to $27.825. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Fully vested as of the date hereof.
/s/ Kimberly Burke, Attorney in fact for Michael J. Ambrogi
2018-05-03